Does telephone intervention affect adherence to antiretroviral therapy in women with human immunodeficiency virus

Autores/as

  • Samyla Citó Pedrosa
    • Ivana Cristina Vieira de Lima
      • Bárbara de Abreu Vasconcelos
        • Gilmara Holanda da Cunha
          • Maria Lúcia Duarte Pereira
            • Marli Teresinha Gimeniz Galvão

              DOI:

              https://doi.org/10.15253/2175-6783.2017000300003

              Palabras clave:

              HIV, Clinical Trial, Medication Adherence, Telephone, Nursing.

              Resumen

              Objective: to evaluate the impact of a telephone intervention on the adherence to antiretroviral therapy in women with human immunodeficiency virus. Methods: quasi experimental study, before and after, conducted ina specialized service with 19 women who live with the human immunodeficiency virus. The study was developedin four phases: recruitment; assessment of adherence to antiretroviral treatment, telephone intervention and reassessment of adherence. During three months of follow-up, eight calls were made to each participant, totaling 152 interventions. Results: there was a statistically significant improvement in the number of participants with adequate adherence (p=0.004) and in the mean of adherence scores (p=0.000) after the intervention. There was no significant impact on the immune status. Conclusion: telephone interventions aimed at women with human immunodeficiency virus developed during three months proved to be effective for improving adherenceto treatment.
              Crossmark - verificar atualizações

              Descargas

              Los datos de descarga aún no están disponibles.

              Descargas

              Publicado

              2017-08-21

              Número

              Sección

              Carta al Editor

              Cómo citar

              1.
              Pedrosa SC, Lima ICV de, Vasconcelos B de A, Cunha GH da, Pereira MLD, Galvão MTG. Does telephone intervention affect adherence to antiretroviral therapy in women with human immunodeficiency virus. Rev Rene [Internet]. 2017 Aug. 21 [cited 2026 Oct. 17];18(3):300-6. Available from: https://periodicos.ufc.br/rene/article/view/20047